Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma

por Zeisel, Mirjam B., Guerrieri, Francesca, Levrero, Massimo
Publicado 2021

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process

por Colpitts, Che C., Tsai, Pei-Ling, Zeisel, Mirjam B.
Publicado 2020

The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond

por Alfano, Vincenzo, Zeisel, Mirjam B., Levrero, Massimo, Guerrieri, Francesca
Publicado 2021

MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin α5β1

por Zeisel, Mirjam B, Druet, Vanessa A, Wachsmann, Dominique, Sibilia, Jean
Publicado 2005

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

por Zeisel, Mirjam B., Crouchet, Emilie, Baumert, Thomas F., Schuster, Catherine
Publicado 2015

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

por Plissonnier, Marie-Laure, Herzog, Katharina, Levrero, Massimo, Zeisel, Mirjam B.
Publicado 2018

Hepatitis C virus infection and related liver disease: the quest for the best animal model

por Mailly, Laurent, Robinet, Eric, Meuleman, Philip, Baumert, Thomas F., Zeisel, Mirjam B.
Publicado 2013

Host-targeting therapies for hepatitis C virus infection: current developments and future applications

por Crouchet, Emilie, Wrensch, Florian, Schuster, Catherine, Zeisel, Mirjam B., Baumert, Thomas F.
Publicado 2018

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

por Verrier, Eloi R., Colpitts, Che C., Schuster, Catherine, Zeisel, Mirjam B., Baumert, Thomas F.
Publicado 2016

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

por Zona, Laetitia, Tawar, Rajiv G., Zeisel, Mirjam B., Schuster, Catherine, Lupberger, Joachim, Baumert, Thomas F.
Publicado 2014

Adaptive Immunity to Hepatitis C Virus

por Zeisel, Mirjam B., Fafi-Kremer, Samira, Robinet, Eric, Habersetzer, François, Baumert, Thomas F., Stoll-Keller, Françoise
Publicado 2009

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

por Wrensch, Florian, Crouchet, Emilie, Ligat, Gaetan, Zeisel, Mirjam B., Keck, Zhen-Yong, Foung, Steven K. H., Schuster, Catherine, Baumert, Thomas F.
Publicado 2018

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection

por Fafi-Kremer, Samira, Fauvelle, Catherine, Felmlee, Daniel J., Zeisel, Mirjam B., Lepiller, Quentin, Fofana, Isabel, Heydmann, Laura, Stoll-Keller, Françoise, Baumert, Thomas F.
Publicado 2012

A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission

por Fofana, Isabel, Xiao, Fei, Thumann, Christine, Turek, Marine, Zona, Laetitia, Tawar, Rajiv G., Grunert, Fritz, Thompson, John, Zeisel, Mirjam B., Baumert, Thomas F.
Publicado 2013

Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors

por Bitzegeio, Julia, Bankwitz, Dorothea, Hueging, Kathrin, Haid, Sibylle, Brohm, Christiane, Zeisel, Mirjam B., Herrmann, Eva, Iken, Marcus, Ott, Michael, Baumert, Thomas F., Pietschmann, Thomas
Publicado 2010

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents

por Xiao, Fei, Fofana, Isabel, Heydmann, Laura, Barth, Heidi, Soulier, Eric, Habersetzer, François, Doffoël, Michel, Bukh, Jens, Patel, Arvind H., Zeisel, Mirjam B., Baumert, Thomas F.
Publicado 2014

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

por Duong, Francois H.T., Trincucci, Gaia, Boldanova, Tujana, Calabrese, Diego, Campana, Benedetta, Krol, Ilona, Durand, Sarah C., Heydmann, Laura, Zeisel, Mirjam B., Baumert, Thomas F., Heim, Markus H.
Publicado 2014

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

por Colpitts, Che C, Tawar, Rajiv G, Mailly, Laurent, Thumann, Christine, Heydmann, Laura, Durand, Sarah C, Xiao, Fei, Robinet, Eric, Pessaux, Patrick, Zeisel, Mirjam B, Baumert, Thomas F
Publicado 2018

Genotype 1 Hepatitis C Virus Envelope Features That Determine Antiviral Response Assessed through Optimal Covariance Networks

por Murray, John M., Moenne-Loccoz, Rémy, Velay, Aurélie, Habersetzer, François, Doffoël, Michel, Gut, Jean-Pierre, Fofana, Isabel, Zeisel, Mirjam B., Stoll-Keller, Françoise, Baumert, Thomas F., Schvoerer, Evelyne
Publicado 2013

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C

por Xiao, Fei, Fofana, Isabel, Thumann, Christine, Mailly, Laurent, Alles, Roxane, Robinet, Eric, Meyer, Nicolas, Schaeffer, Mickaël, Habersetzer, François, Doffoël, Michel, Leyssen, Pieter, Neyts, Johan, Zeisel, Mirjam B, Baumert, Thomas F
Publicado 2015